Sensitivity of PCR targeting Mycobacterium ulcerans by use of Fine-needle aspirates for diagnosis of Buruli ulcer∇

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 924-926

  Phillips, R O ^a,b   Sarfo, F S ^b   Osei Sarpong, F ^c   Boateng, A ^c   Tetteh, I ^b   Lartey, A ^b   Adentwe, E ^c   Opare, W ^d   Asiedu, K B ^e   Wansbrough Jones, M ^f,g  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c Tepa Government Hospital   (Ghana)

^d National Buruli Ulcer Control Programme   (Ghana)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^g ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BACTERIUM CULTURE; BURULI ULCER; CLINICAL ARTICLE; GENE INSERTION SEQUENCE; GENE TARGETING; HUMAN; HUMAN TISSUE; MICROSCOPY; MINIMALLY INVASIVE PROCEDURE; MYCOBACTERIUM ULCERANS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUNCH BIOPSY; SENSITIVITY AND SPECIFICITY; ADOLESCENT; ADULT; CHILD; COMPARATIVE STUDY; EVALUATION; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; NEEDLE BIOPSY; TRANSPOSON;

MYCOBACTERIUM ULCERANS;

BACTERIAL DNA;

ADOLESCENT; ADULT; BIOPSY, FINE-NEEDLE; BURULI ULCER; CHILD; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; FEMALE; HUMANS; MALE; MYCOBACTERIUM ULCERANS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 65249139909     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01842-08     Document Type: Article

References (16)

1. Amofah, G., S. Asamoah, and C. Afram-Gyening. 1998. Effectiveness of excision of pre-ulcerative Buruli lesions in field situations in a rural district in Ghana. Trop. Doct. 28:81-83.
2. Asiedu, K., and R. M. Scherpbier (ed.). 2000. Buruli ulcer: Mycobacterium ulcerans infection. WHO/CDS/CPE/GBUI/2000.1. World Health Organization, Geneva, Switzerland.
3. Buntine, J., and K. E. Crofts. 2001. Buruli ulcer: management of Mycobacterium ulcerans disease. A manual for health care providers. World Health Organization, Geneva, Switzerland. http://www.who.int/gtb-buruli/publications /index.html.
4. Chauty, A., M. F. Ardant, A. Adeye, H. Euverte, A. Guedenon, C. Johnson, J. Aubry, E. Nuermberger, and J. Grosset. 2007. Promising clinical efficacy of the combination streptomycin-rifampin for the treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob. Agents Chemother. 51:4029-4035.
5. Debacker, M., J. Aguiar, C. Steunou, C. Zinsou, W. M. Meyers, and F. Portaels. 2005. Buruli ulcer recurrence, Benin. Emerg. Infect. Dis. 11:584-589.
6. Ersoz, C., A. Polat, M. S. Serin, L. Soylu, and O. Demircan. 1998. Fine needle aspiration (FNA) cytology in tuberculous lymphadenitis. Cytopathol-ogy 9:201-207.
7. Lester, J., and M. D. Layfield. 2007. Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis. Diagn. Cytopathol. 35:798-805.
8. Molyneux, D., P. Hotez, and A. Fenwick. 2005. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2:e336.
9. Pettit, J. H., N. J. Marchette, and R. J. Rees. 1966. Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. Br. J. Dermatol. 78:187-197.
10. Phillips, R., C. Horsfield, S. Kuijper, A. Lartey, I. Tetteh, S. Etuaful, B. Nyamekye, P. Awuah, K. M. Nyarko, F. Osei-Sarpong, S. Lucas, A. H. Kolk, and M. Wansbrough-Jones. 2005. Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an assay using punch biopsy specimens for diagnosis of Buruli ulcer. J. Clin. Microbiol. 43:3650-3656.
11. Portaels, F., J. Agular, K. Fissette, P. A. Fonteyne, H. De Beenhouwer, P. de Rijk, A. Guedenon, R. Lemans, C. Steunou, C. Zinsou, J. M. Dumonceau, and W. M. Meyers. 1997. Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J. Clin. Microbiol. 35:1097-1100.
12. Portaels, F., P. A. Fonteyene, H. de Beenhouwer, P. de Rijk, A. Guedenon, J. Hayman, and M. W. Meyers. 1996. Variability in 3' end of 16S rRNA sequence of Mycobacterium ulcerans is related to geographic origin of isolates. J. Clin. Microbiol. 34:962-965.
13. Portaels, F., P. Johnson, and W. E. Meyers. 2001. Buruli ulcer: diagnosis of Mycobacterium ulcerans disease. World Heath Organization, Geneva, Switzerland. http://www.who.int/gtb-buruli/publications//PDF/BURULI- diagnosis.pdf.
14. Revill, W. D., R. H. Morrow, M. C. Pike, and J. Ateng. 1973. A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet ii:873-877.
15. Stinear, T., J. K. Davies, G. A. Jenkin, F. Portaels, B. C. Ross, F. Oppe-disano, M. Purcell, J. A. Hayman, and P. D. Johnson. 2000. A simple PCR method for rapid genotype analysis of Mycobacterium ulcerans. J. Clin. Microbiol. 38:1482-1487.
16. WHO. 2004. Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). WHO, Geneva, Switzerland. http://www.who.int/gtb-buruli/publications.